Sandoz Sets Generics Focus As US Sale Awaits
Believes Clearance For US Divestment To Aurobindo Is Imminent
New Sandoz chief Richard Saynor says the division is undergoing a transformation towards building a generics-focused business. Meanwhile, the company is still waiting to close the sale of its US oral-dose and dermatology operations to Aurobindo.
